Drug-Induced Progressive Multifocal Leukoencephalopathy: Lessons Learned From Contrasting Natalizumab and Rituximab

Autor: Vermeer, N S, Straus, S M J M, Mantel-Teeuwisse, A K, Hidalgo-Simon, A, Egberts, A C G, Leufkens, H G M, De Bruin, M L, Sub Pharmacoepidemiology, Sub Pharmacotherapy, Theoretical, Sub Clinical Pharmacy, Pharmacoepi, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Clinical Pharmacology & Therapeutics, 98(5), 542-550. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 98(5), 542. Nature Publishing Group
Europe PubMed Central
Clinical Pharmacology & Therapeutics, 98(5), 542. Nature Publishing Group

Progressive multifocal leukoencephalopathy (PML) has been identified as a serious adverse drug reaction (ADR) of several immunomodulatory biologicals. In this study, we contrasted the reporting patterns of PML for two biologicals for which the risk w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c15989e33b71516a73e76c03222e9d22
https://pure.eur.nl/en/publications/a453c7f2-9895-46c5-85f8-ca2650e71546

Bijwerkingen na influenzavaccinatie: reactie op enkele incidenten en het belang van centrale registratie

Autor: Swaan, C. M., van der Sande, M. A. B., Speelman, P., Conyn-van Spaendonck, M. A. E., Straus, S. M. J. M., Coutinho, R. A.

Publikováno v: Nederlands tijdschrift voor geneeskunde, 151(39), 2166-2169. Bohn Stafleu van Loghum

The influenza vaccine is considered safe, but information on vaccine-related adverse events is limited and a nationwide overview of adverse events is lacking. In 2006, after deaths occurred in Israel and the Netherlands following influenza vaccinatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::552564af07a17534784bed80c07af425
https://pure.amc.nl/en/publications/bijwerkingen-na-influenzavaccinatie-reactie-op-enkele-incidenten-en-het-belang-van-centrale-registratie(065faa20-33f7-45ef-bb71-9bea0f0141d7).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.